GSK to review drug pricing policy: pharmaceuticals giant reacts to criticism over costs to poor countries
17 March 2001. Related: Treatment access.
2001
Oxfam launches stinging attack on drug industry over cheap medicines ban
17 March 2001. Related: Treatment access.
Companies weigh offer of royalties for AIDS drugs aimed at Africa
17 March 2001. Related: Treatment access.
Drugs need not be stopped because of neutropenia in HIV-positive patients
17 March 2001. Related: Antiretrovirals, Side effects.
Effective antiretroviral therapy resolves HIV organ-specific complications in 3 children
17 March 2001. Related: Paediatric care.
Seroconversion in Kenyan sex-workers linked with reduced HIV-specific immune response
17 March 2001. Related: Women's health.
Prevalence and correlates of anaemia in a large cohort of HIV-positive women
17 March 2001. Related: Women's health, Side effects.
HIV-related fatigue relieved by psychostimulants
17 March 2001. Related: Side effects.
Studies underway on metabolic side effects of antiretrovirals
17 March 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Lactic acidosis in pregnant women receiving d4T (stavudine) and ddI (didanosine): EMEA issue statement
17 March 2001. Related: Women's health, Pregnancy, Side effects.
UK to start trials of new cervical cancer vaccine
17 March 2001. Related: Other news.
Anal HPV infection common in HIV positive and high-risk HIV negative women
17 March 2001. Related: Women's health.
Plasma cysteine deficiency and decreased reduction of nitrososulfa-methoxazole with HIV Infection
17 March 2001. Related: Side effects.
Capravirine clinical trials restricted: additional safety evaluation required
17 March 2001. Related: Antiretrovirals.
Gilead announces start of early access program for investigational anti-HIV agent tenofovir DF in United States and France
17 March 2001. Related: Antiretrovirals.
Mortality from liver disease increasing in HIV-positive patients
17 March 2001. Related: Other news.
First European guidelines for HIV-1 drug resistance testing (2001)
17 March 2001. Related: Guidelines, Drug resistance.
US HIV treatment guidelines updated for adults and adolescents (March 2001)
17 March 2001. Related: Guidelines.
US perinatal treatment guidelines updated
17 March 2001. Related: Pregnancy, Guidelines.
Differentiating within and between drug classes: sometimes it’s toxicity, sometimes its efficacy
17 March 2001. Related: Conference reports, Antiretrovirals.
Intermittent versus continuous HAART
17 March 2001. Related: Conference reports.
Viral load “blips” and eventual rebound
17 March 2001. Related: Conference reports.
Interaction between garlic and saquinavir and underreporting of alternative treatment use
17 March 2001. Related: Conference reports, PK and drug interactions.
Solid organ transplant in HIV/hepatitis co-infected patients
17 March 2001. Related: Conference reports, Hepatitis coinfection.
HIV and women – overview
17 March 2001. Related: Conference reports, Women's health, Pregnancy.
Update on HIV drug resistance
17 March 2001. Related: Conference reports, Drug resistance.
Update and review of bone studies
17 March 2001. Related: Conference reports.
Treatment interruptions, structured and unplanned, immunotherapy and what’s in store
17 March 2001. Related: Conference reports.
Primary infection and treatment issues
17 March 2001. Related: Conference reports.
Volume 2 Number 2 March 2001 PDF
1 March 2001. Related: PDFs.
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures – worldwide, 1997-2000
17 January 2001. Related: Treatment alerts.
US FDA and Bristol-Myers Squibb issue caution for combination HIV therapy with stavudine (d4T) and didanosine (ddI) in pregnant women
17 January 2001. Related: Treatment alerts, Women's health, Pregnancy.
French guidelines updated
17 January 2001. Related: Guidelines.
Diagnosis of acute HIV infection: it’s time to get moving!
17 January 2001. Related: HIV prevention and transmission.
HAART initiated during primary HIV infection leads to faster and more complete immune reconstitution
17 January 2001. Related: Antiretrovirals.
Viral response to antiretroviral therapy slower during acute HIV-1 infection
17 January 2001. Related: Antiretrovirals.
Is the chance to cut a chance to cure? The Caesarean section controversy revisited
17 January 2001. Related: Pregnancy.
HIV infection increases susceptibility to Chlamydia trachomatis pelvic inflammatory disease
17 January 2001. Related: Women's health.
Protease inhibitors safe and effective in HIV-positive pregnant women
17 January 2001. Related: Pregnancy.
Pregnancy does not accelerate progression of HIV-1 infection
17 January 2001. Related: Women's health, Pregnancy.
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7
17 January 2001. Related: Cancer and HIV.
Will cidofovir be useful against cervical lesions?
17 January 2001. Related: Cancer and HIV.
Vitamin based protocol for the treatment for lactic acidosis
17 January 2001. Related: Side effects.
Osteonecrosis in HIV
17 January 2001. Related: Side effects.
Indinavir nephrolithiasis more prevalent than initially thought
17 January 2001. Related: Side effects.
HIV protease inhibitors associated with hepatic cytolysis
17 January 2001. Related: Side effects, Hepatitis coinfection.
Inflammatory stimulus may contribute to HIV lipodystrophy
17 January 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Alpha-1 antitrypsin, a natural protein may block HIV
17 January 2001. Related: Other news.
European Commission approves GlaxoSmithKline’s HIV triple therapy Trizivir
17 January 2001. Related: Antiretrovirals.
Lamivudine withdrawal may reactivate HBV in HIV-positive patients
17 January 2001. Related: Antiretrovirals, Hepatitis coinfection.
CPMP delivers positive opinion on Kaletra
17 January 2001. Related: Antiretrovirals.
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa
17 January 2001. Related: Other news.
Human papillomavirus (HPV) may speed HIV progression
17 January 2001. Related: Women's health, Cancer and HIV.
Influenza vaccination does not accelerate HIV infection
17 January 2001. Related: Other news.
Nef gene defects identified in paediatric long-term HIV survivors
17 January 2001. Related: Basic science and immunology.
Medication adherence poor for many HIV-infected children
17 January 2001. Related: Paediatric care.
Oral ganciclovir safe, effective for children co-infected with CMV and HIV
17 January 2001. Related: Paediatric care, Coinfections and complications.
High cancer incidence in perinatally HIV-infected children
17 January 2001. Related: Paediatric care, Cancer and HIV.
Functional aerobic impairment detected in HIV-seropositive teens
17 January 2001. Related: Paediatric care.
NIH scientists highlight role of macrophages in HIV infection
17 January 2001. Related: Basic science and immunology.
Chronically infected HIV patients can mount anti-HIV immune response
17 January 2001. Related: Basic science and immunology.
Structured treatment interruption: important controlled trial in monkeys
17 January 2001. Related: Basic science and immunology.
Baseline HIV levels, age determine degree of immune restoration with treatment
17 January 2001. Related: Basic science and immunology.
Anti-HIV CD4+ and CD8+ assay allows rapid estimation of anti-HIV T cell response
17 January 2001. Related: Basic science and immunology.
Interleukin-7 mediates T-cell homeostasis and increases HIV-1 replication
17 January 2001. Related: Basic science and immunology.